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Abstract
Background: The purpose of this study was to reduce the number of items, create a scoring method and assess the 
psychometric properties of the Freedom from Glasses Value Scale (FGVS), which measures benefits of freedom from 
glasses perceived by cataract and presbyopic patients after multifocal intraocular lens (IOL) surgery.
Methods: The 21-item FGVS, developed simultaneously in French and Spanish, was administered by phone during an 
observational study to 152 French and 152 Spanish patients who had undergone cataract or presbyopia surgery at 
least 1 year before the study. Reduction of items and creation of the scoring method employed statistical methods 
(principal component analysis, multitrait analysis) and content analysis. Psychometric properties (validation of the 
structure, internal consistency reliability, and known-group validity) of the resulting version were assessed in the 
pooled population and per country.
Results: One item was deleted and 3 were kept but not aggregated in a dimension. The other 17 items were grouped 
into 2 dimensions ('global evaluation', 9 items; 'advantages', 8 items) and divided into 5 sub-dimensions, with higher 
scores indicating higher benefit of surgery. The structure was validated (good item convergent and discriminant 
validity). Internal consistency reliability was good for all dimensions and sub-dimensions (Cronbach's alphas above 
0.70). The FGVS was able to discriminate between patients wearing glasses or not after surgery (higher scores for 
patients not wearing glasses). FGVS scores were significantly higher in Spain than France; however, the measure had 
similar psychometric performances in both countries.
Conclusions: The FGVS is a valid and reliable instrument measuring benefits of freedom from glasses perceived by 
cataract and presbyopic patients after multifocal IOL surgery.
Background
Cataracts and presbyopia are both conditions that cause
visual impairment. Cataracts, responsible for almost half
the cases of blindness worldwide [1], are cloudy areas of
accumulated protein that form on the lens of the eye,
causing blurred and reduced vision, faded color percep-
tion, glare, light sensitivity and impaired night vision.
Presbyopia is the loss of the natural lens' flexibility, which
makes it difficult to focus on close objects. Age is the
major cause of development for both cataracts and pres-
byopia. Many aspects of patients' daily lives are affected
by these two conditions, and there is increasing interest
in evaluating their impacts on patients' quality of life [2-
6].
Surgery, consisting of the replacement of the natural
lens by an intraocular lens (IOL), is the only effective
treatment for cataracts [7]. More recently, presbyopia-
correcting lenses have been used to treat presbyopia in
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patients undergoing cataract surgery [8,9]. The benefits
of cataract surgery for patients' visual functioning, satis-
faction and quality of life are well-documented in the lit-
erature [4,10-16]. Monofocal IOL implantation allows
either distance or near vision to be corrected, so patients
with both problems still need to wear glasses to correct
the one or the other visual impairment. Multifocal IOLs
were then developed to restore both distance and near
vision and, consequently, to free patients from glasses.
Several multifocal intraocular implants have been spe-
cifically designed as an option for cataract surgery lens
r e p l a c e m e n t ,  a s  w e l l  a s  f o r  p a t i e n t s  w i t h  p r e s b y o p i a .
Their safety and efficacy, as well as benefit for visual func-
tioning and patient satisfaction, are well-reported in the
literature [10,14,16-25]. However, the value for patients of
no longer requiring glasses has not been specifically doc-
umented. Typical measures used to assess the benefit of
IOLs include clinical parameters, a functional test of
visual acuity and some functional Patient-Reported Out-
come (PRO) scales (e.g. TyPE questionnaire [26], Visual
Function Index (VF-14) [27]). Some other PRO scales
were specifically designed to measure the impact of assis-
tive devices or correction - either with glasses or contact
lenses - on patients' quality of life (e.g. Quality of Life
Impact of Refractive Correction questionnaire (QIRC)
[28], Contact Lens Impact on Quality of Life (CLIQ) [29],
Psychosocial Impact of Assistive Devices (PIADs) [30]).
To our knowledge, no existing PRO scales assess the per-
ceived patient benefit of freedom from glasses. A specific
questionnaire, the Freedom from Glasses Value Scale
(FGVS©), was developed [31] for this purpose and admin-
istered to French and Spanish patients during an observa-
tional study.
The objectives of this paper are to present the item
reduction process and creation of the scoring method for
the FGVS, and then to assess the psychometric properties
of the resulting version of the measure.
Methods
The FGVS
The FGVS was developed simultaneously in French and
Spanish following patient interviews and the develop-
ment of a conceptual framework comprising 9 global
concepts identified from analysis of the exploratory
patient interviews [31]. Based on these concepts, 21 items
were generated: global vision (1 item), impact of eye sur-
gery on patients' lives (1 item), practical constraints
related to wearing glasses (1 item), improvement of prac-
tical issues without glasses (8 items), improvement of
psychological constraints without glasses (5 items), phys-
ical appearance/aesthetic aspect (self image) (1 item),
physical appearance/aesthetic aspect (in the eyes of oth-
ers) (1 item), eyesight problems left behind (1 item) and
recommendation of surgery to others (2 items). All items
had 5-point Likert response scales, ranging from "much
better" to "much worse", "very positive" to "very negative",
"no, not at all" to "yes, absolutely", "totally agree" to
"totally disagree" or "definitely better without glasses" to
"definitely better with glasses".
Patients and study design
An observational, cross-sectional, non-comparative, mul-
ticentre study was conducted in France and Spain
between June 2007 and January 2008 involving patients
who had a ReSTOR® lens implanted in both eyes, with the
last eye operated at least 1 year before the inclusion date.
Centres were selected from each country in which sur-
geons were experienced ReSTOR users and had
implanted numerous lenses in the preceding 18 months.
Patients included were all over 49 years old, with age-
related cataract or bilateral presbyopia. They had cataract
or presbyopia surgery using phaco-emulsification with
IOL implantation in the posterior chamber resulting in
post-operative emmetropia. None had refractive surgery
before the ReSTOR lens implantation (i.e. LASIK and
PRK) or a ReSTOR lens implanted as part of a clinical
trial. None had intra-operative difficulties that required
them to later wear glasses, post-operative complications
necessitating a refractive correction, or concomitant ocu-
lar diseases at the time of surgery deteriorating the visual
acuity prognosis. Patients meeting the inclusion criteria
were selected from an exhaustive list of cases. The target
sample included about 150 patients per country. In addi-
tion to refining and assessing the psychometric proper-
ties of the FGVS, another objective of this study was to
find the percentage of ReSTOR IOL patients who do not
need glasses 1 year after cataract or presbyopia surgery,
and to explore patients' degree of satisfaction with this
technology.
The FGVS was administered by phone. Information
about patients' use of glasses before and after surgery was
collected. Patients' age and gender, clinical characteristics
before surgery (general and ocular co-morbidities), vision
before surgery, and related information after surgery
(posterior capsular opacification, refractive surgery, other
ocular diseases) were collected from patient charts.
This study was conducted in compliance with the ethi-
cal principles derived from the Declaration of Helsinki,
the ADELF (the Association of the French-speaking epi-
demiologists) and the Good Epidemiology Practices. All
patients participating in the study signed a written con-
sent prior to their inclusion. This study received approval
of the CNIL (the French data protection permanent com-
mittee, authorization N° 907054), the CCTIRS (the
French advisory committee dealing with data processing
on health research) and the CNOM (the French council
of the college of physicians) for France. This study also
received approval of the AEMPS (the Spanish agency ofBerdeaux et al. BMC Ophthalmology 2010, 10:15
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drugs and health products) and Comité Ético de Investi-
gación Clínica Regional del Principado de Asturias (the
ethical committee of clinical research of the Principality
of Asturias) for Spain.
Statistical analyses
Analysis population
The analysis population included all patients for whom
the FGVS was completed and considered assessable (i.e.
at least 50% of the items were completed). Unless other-
wise specified, all statistical analyses were performed on
these patients overall as well as by country with a com-
parison of results between countries.
Item reduction and creation of the scoring method for the 
FGVS
The quality of completion of the FGVS was first analyzed
for all FGVS questionnaires received. Item reduction and
creation of the scoring method were then conducted
using data from patients who completed all FGVS items.
Three statistical methods were used to define the struc-
ture of the FGVS. First, a Principal Component Analysis
(PCA) with varimax rotation was performed to identify
the structure of the questionnaire; the retained factors
were those with an eigenvalue greater than 1. The struc-
ture of the questionnaire was compared between coun-
tries, and items not loading on the same scale in both
countries were considered for deletion. Second, a multi-
trait analysis was performed to explore and confirm the
structure identified by the PCA. Item convergent and dis-
criminant validity [32] were analyzed (item convergent
validity criterion: the correlation between each item and
its own hypothesized scale should be higher than 0.40;
item discriminant validity criterion: each item should
correlate more highly with its own hypothesized scale
than with the other scales). Items not loading well on
their hypothesized scale were considered for deletion.
Lastly, Cronbach's alpha [33] for each scale was analyzed,
with a recommended value of at least 0.70 [34]. In addi-
tion to using these statistical methods, the final structure
of the FGVS was defined based on the content of the
items.
Psychometric properties of the FGVS
A multitrait analysis was conducted on the analysis popu-
lation to validate the structure of the FGVS created using
the previous analyses. The internal consistency of the
FGVS was assessed using Cronbach's alpha for each scale.
Percentages at floor and at ceiling were checked to ensure
there were no issues related to a high percentage of
patients having the lowest or the highest possible score.
Known-group validity of the FGVS (the extent to which
the FGVS is able to detect variability among patients who
are known to differ on various parameters) was analyzed
by comparing all scores between subgroups of patients
based on wearing glasses before and after surgery, other
ocular diseases since surgery, age, gender and country.
Statistical tests, level of significance and software
A chi-square test was used when comparing a categorical
variable between subgroups of patients. A Mann-Whit-
ney-Wilcoxon test was used when comparing a continu-
ous variable between 2 subgroups of patients. A Kruskal-
Wallis test was employed when comparing a continuous
variable between more than 2 subgroups of patients. The
threshold for statistical significance was fixed at 5%. All
analyses were performed using SAS software for Win-
dows (Version 9; SAS Institute, Inc., Cary, NC, USA).
Results
Patients' characteristics
Among the 346 patients approached to participate in the
study, the 304 patients finally included in the study were
kept in the analysis population as they all completed at
least 50% of FGVS items. The mean age was 66, with a
majority of females (66%). Before surgery, two-thirds of
patients had hyperopia (67%), about half had astigmatism
(49%) and about a quarter had myopia (28%). About 16%
of the patients had ReSTOR implanted for presbyopia.
O n l y  7 %  o f  t h e  p a t i e n t s  d i d  n o t  h a v e  t o  w e a r  g l a s s e s
before surgery, whereas 87% were independent from
glasses after surgery. A large majority of patients did not
develop new eye disease and did not present posterior
capsular opacification 1 year after surgery (93% and 85%
respectively).
As shown in Table 1, the 152 French and 152 Spanish
patients were comparable regarding age, gender, wearing
glasses before and after surgery, and development of
other ocular disease after surgery. However, statistically
significant differences were observed between France and
Spain in the percentages of patients with myopia, hypero-
pia and astigmatism before surgery; there was a higher
percentage of patients with myopia and astigmatism in
Spain, and a higher percentage of patients with hyperopia
in France.
Quality of completion
The quality of completion of the FGVS was very good,
with only 9 missing data (3%) observed both for item 17
("self-image") and item 18 ("other people's image of you").
These missing data were for French patients; no missing
data were observed for Spanish patients.
Distribution of FGVS items
For each of the 21 FGVS items, the majority of patients
answered positively (more comfort, less worry, less
bother, etc.), with the percentage of positive answers
ranging from 51% for item 18 "other people's image of
you" to 93% for item 2 "change in life since operation"
(Table 2). Spanish patients tended to answer more posi-Berdeaux et al. BMC Ophthalmology 2010, 10:15
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tively than French patients, whatever the item (percent-
age of positive answers ranging from 57% to 95% with a
mean of 77% for Spanish patients; percentage of positive
answers ranging from 39% to 93% with a mean of 69% for
French patients). Spanish patients also used the central
a n sw e r  c h o i c e  m o r e  o ft e n  t h a n  F r e n c h  pa t i e n ts  ( m e a n
percentage of central answer: 18% for Spanish patients;
10% for French patients), whereas French patients used
the intermediate answer choices (answers 2 or 4 over a 1-
5 range) more often (mean percentage of intermediate
answers: 36% for French patients; 11% for Spanish
patients).
Item reduction and creation of the scoring method for the 
FGVS
The item reduction was conducted using data from the
295 patients who completed all FGVS items (143 in
France and 152 in Spain). As shown in Table 3, the PCA
conducted on the 21 FGVS items resulted in four factors
with an eigenvalue greater than 1, explaining 66% of the
total variance. Item 15 ("feel younger since operation")
was deleted from the questionnaire as it loaded on several
scales with the global PCA, and did not load on the same
scale with PCAs conducted on French and Spanish
patients separately. The final structure of the question-
Table 1: Patients' characteristics per country (n = 152 for France, n = 152 for Spain).
France (n = 152) Spain (n = 152) p-value of the 
difference*
Patients' socio-demographic characteristics
Age (years) Mean (STD) 65 (7.5) 67 (8.9) 0.166
Median (min - max) 66 (51 - 80) 66 (51 - 83)
Gender Males (%) 36 32 0.468
Patients' characteristics before surgery
Myopia (%) 22 34 0.010
Patients' vision** Hyperopia (%) 74 59 0.012
Astigmatism (%) 35 63 < 0.001
Yes, multifocals (%) 59 60
Wearing glasses Yes, single vision (%) 36 30 0.237
Yes, unknown type (%) 2 1
No (%) 4 9
Best corrected visual 
acuity
Mean (STD) 0.8 (0.2) 0.7 (0.2) < 0.001
Median (min - max) 0.9 (0.3 - 1.2) 0.8 (0.1 - 1.0)
Patients' characteristics after surgery
Yes, always (%) 3 7
Wearing glasses Yes, sometimes (%) 9 7 0.138
No/Never (%) 88 86
Other ocular disease (%) 7 7 0.821
* Chi-square test for categorical variables, Mann-Whitney-Wilcoxon test for continuous variables
In bold and italic, statistically significant p-values
** Myopia, hyperopia and astigmatism may occur simultaneously for some patients, explaining a total percentage by country higher than 
100% for patients' visionBerdeaux et al. BMC Ophthalmology 2010, 10:15
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naire, presented in Table 4, uses 20 of the 21 original
FGVS items. Items 3 ("bother of wearing glasses"), 17
("self-image") and 18 ("other people's image of you"), cor-
responding to the fourth factor of the PCA, were kept but
not aggregated in a dimension. Item 3 loaded on several
scales. The content of items 17 and 18 was considered
off-topic as they did not refer to the surgery or advan-
tages of freedom from glasses, and missing data were
observed for these 2 items in French patients. However,
as these 3 items might be good predictors of the patients'
motivation for surgery, these items were retained in the
questionnaire. The other 17 items were grouped into 2
dimensions ('global evaluation', 9 items; 'advantages', 8
items). This structure, based on the results of the PCA,
was confirmed by the results of the multitrait analysis,
with all items meeting both the convergent and discrimi-
nant validity criteria, and the Cronbach's alpha values of
each dimension exceeding 0.70. The 2 dimensions were
then divided into 5 sub-dimensions based on the content
of the items: 'global evaluation' was divided into 'evalua-
tion of the result' (2 items), 'feelings' (4 items) and 'global
judgment' (3 items); 'advantages' was divided into 'psy-
chological advantages' (3 items) and 'practical advantages'
(5 items). The results of the multitrait analysis for these 5
sub-dimensions were good, with all items meeting the
convergent validity criterion and only a few items not
meeting the discriminant validity criterion. The Cron-
bach's alpha was above 0.70 for the 5 sub-dimensions.
Scale-scale correlations between the 5 sub-dimensions
ranged between 0.27 and 0.66, indicating a link but no
redundancy between the sub-dimensions, reinforcing the
decision to keep them in the final structure of the FGVS.
In terms of calculation of scores, all item scales were
reversed so that a higher item score reflects a more posi-
tive answer. A score was then calculated for each dimen-
sion and sub-dimension as the mean of reversed items in
the dimension/sub-dimension. All dimension and sub-
dimension scores ranged from 1 to 5, with a higher score
indicating a more positive evaluation and greater advan-
tages of freedom from glasses. To handle missing data,
sub-dimension scores were calculated if at least 1 item of
the sub-dimension was completed, and dimension scores
Table 2: Patients' answers to the FGVS items (N = 304).
Content of FGVS© items Positive answers (%) Central answer (%) Negative answers (%)
1. Evaluation of eyesight since operation 88.16 5.59 6.25
2. Change in life since operation 93.09 2.96 3.95
3. Bother of wearing glasses 78.95 6.25 14.80
Stop wearing glasses because...
4. Lenses steaming up 61.18 22.37 16.45
5. Sliding down nose 61.84 21.38 16.78
6. Cleaning lenses 70.07 17.11 12.83
7. Frames restrictive 51.97 22.37 25.66
8. No worry about breaking glasses 59.87 17.76 22.37
9. No worry about scratching glasses 61.18 18.42 20.39
10. No worry about losing glasses 64.14 14.80 21.05
11. Pressing on nose 60.86 19.41 19.74
Feelings since operation...
12. Comfort 89.14 5.26 5.59
13. Freedom 90.79 4.28 4.93
14. Well-being 87.83 6.58 5.59
15. Youth 60.20 21.05 18.75
16. Having new eyes 74.34 11.18 14.47
17. Self-image 70.39 19.74 6.91
18. Other people's image of you 50.66 41.78 4.61
19. Eyesight problems in the past 77.96 11.18 10.86
20. Willingness to undergo surgery again 89.80 2.96 7.24
21. Willingness to recommend to others 88.49 3.95 7.57Berdeaux et al. BMC Ophthalmology 2010, 10:15
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Table 3: Results of the PCA conducted on FGVS items (N = 295).
F a c t o r  1F a c t o r  2F a c t o r  3F a c t o r  4
Eigenvalue for each factor 8.51 2.98 1.32 1.11
Proportion of variance explained by each factor 0.41 0.14 0.06 0.05
Factor loadings for each item:
2. Change in life since operation 0.84 0.21 0.03 0.07
12. Feelings since operation... Comfort 0.84 0.14 0.22 0.20
20. Willingness to undergo surgery again 0.83 0.11 0.01 0.01
14. Feelings since operation... Well-being 0.82 0.11 0.18 0.30
13. Feelings since operation... Freedom 0.82 0.08 0.17 0.26
19. Eyesight problems in the past 0.76 0.11 0.15 0.10
21. Willingness to recommend to others 0.76 0.07 0.07 0.06
1. Evaluation of eyesight since operation 0.73 0.23 -0.03 -0.07
16. Feelings since operation... Having new eyes 0.68 0.13 0.20 0.25
15. Feelings since operation... Youth 0.55 0.12 0.13 0.41
10. Stop wearing glasses because... No worry about losing glasses 0.14 0.86 0.10 0.15
8. Stop wearing glasses because... No worry about breaking glasses 0.21 0.83 0.22 0.10
9. Stop wearing glasses because... No worry about scratching glasses 0.17 0.80 0.33 0.10
11. Stop wearing glasses because... Pressing on nose 0.15 0.57 0.27 0.19
7. Stop wearing glasses because... Frames restrictive 0.20 0.51 0.44 0.11
5. Stop wearing glasses because... Sliding down nose 0.11 0.20 0.79 0.16
6. Stop wearing glasses because... Cleaning lenses 0.17 0.29 0.78 0.13
4. Stop wearing glasses because... Lenses steaming up 0.09 0.33 0.74 -0.05
17. Self-image 0.20 0.13 0.00 0.83
18. Other people's image of you 0.14 0.21 0.09 0.69
3. Bother of wearing glasses -0.14 -0.09 -0.41 -0.50
were calculated only if all corresponding sub-dimensions
were scored.
Psychometric properties of the FGVS
As presented in Table 5, the multitrait analyses con-
ducted on the overall analysis population to validate the 2
dimensions and 5 sub-dimensions of the FGVS showed
that all items met the convergent validity criterion. Only a
few items did not meet the discriminant validity criterion
(1 item in the 'evaluation of the result' sub-dimension, 1
item in the 'global judgment' sub-dimension and 1 item in
the 'practical advantages' sub-dimension). The Cron-
bach's alpha was higher than the recommended 0.70
threshold for the 2 dimensions (0.93 for 'global evalua-
tion' and 0.89 for 'advantages'), as well as for all sub-
dimensions (ranging from 0.78 for 'evaluation of the
result' to 0.91 for 'feelings'), indicating good internal con-
sistency reliability. A ceiling effect was observed for the 2
dimension scores (32.2% for 'global evaluation' and 18.4%
for 'advantages'), as well as for all sub-dimension scores
(ranging from 20.1% for 'psychological advantages' to
56.6% for 'evaluation of the result'). No floor effect was
observed, either for the 2 dimension scores or for the 5
sub-dimension scores. Similar results were found in
France and Spain.
Patients not wearing glasses after surgery reported
higher 'global evaluation' and 'advantages' dimension
scores (mean score of 4.6 and 3.9 respectively), indicating
a better global evaluation and greater advantages than
patients wearing glasses (mean scores lower than 4.0 and
3.5, respectively). As shown in Table 6, these differencesBerdeaux et al. BMC Ophthalmology 2010, 10:15
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were statistically significant, and the differences in the 5
sub-dimension scores were also statistically significant
between those patients, with higher scores for patients
not wearing glasses after surgery. Patients with no ocular
co-morbidity after surgery reported a higher 'global eval-
uation' score (mean 4.5), indicating a better global evalua-
tion, than those with an ocular co-morbidity after surgery
(n = 21, mean score of 3.8). This difference was statisti-
cally significant. Regarding the 'global evaluation' dimen-
sion, only the difference in the 'evaluation of the result'
sub-dimension score was statistically significant between
those patients, with a higher score for patients who did
not develop another ocular disease after surgery. The
comparison of the FGVS sub-dimension and dimension
scores between groups of patients based on the wearing
of glasses before surgery, age and gender had non-signifi-
cant results. Statistically significant differences in 'global
evaluation' and 'advantages' dimension scores and the 5
sub-scores were observed between France and Spain,
with higher scores for Spanish patients, indicating a bet-
ter global evaluation and greater advantages.
Table 4: Final structure of the FGVS.
Item Sub-dimension Dimension
Number Label
1 Evaluation of eyesight since 
operation
Evaluation of the result
2 Change in life since operation
Feelings since operation
12 ... Comfort
13 ... Freedom Feelings
14 ... Well-being Global evaluation
16 ... Having new eyes
19 Eyesight problems in the past
20 Willingness to undergo 
surgery again
Global judgment
21 Willingness to recommend to 
others
Stop wearing glasses because
4 ... Lenses steaming up
5 ... Sliding down nose Practical
6 ... Cleaning lenses advantages
7 ... Frames restrictive Advantages
11 ... Pressing on nose
8 ... No worry about breaking 
glasses
9 ... No worry about scratching 
glasses
Psychological
10 ... No worry about losing 
glasses
advantages
3B o t h e r  o f  w e a r i n g  g l a s s e s
17 Self-image Not aggregated in a dimension
18 Other people's image of youBerdeaux et al. BMC Ophthalmology 2010, 10:15
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Discussion
The FGVS, which measures benefits of freedom from
glasses perceived by cataract and presbyopic patients
after multifocal IOL surgery, was administered to French
and Spanish patients who had had a ReSTOR lens
implanted in both eyes, with the last lens implanted at
least 1 year before inclusion in the study. The large major-
ity of patients included in the study had ReSTOR
implanted for cataracts. Subjective refraction parameters
before surgery were not collected and the high hyperopia
i n c i d e n c e  r a t e  i s  l i k e l y  t o  i n c l u d e  a  m a j o r i t y  o f  m i l d
hyperopia. This high rate of hyperopia might influence
the spectacle independence rate. This possible selection
bias can only be definitely addressed using a randomized
clinical trial. The FGVS was well accepted by all patients
as very few missing data were observed. Only a small per-
centage of French patients did not answer when they
were asked about their physical appearance and aesthetic
aspects (i.e. preference with or without glasses).
The final version of the FGVS showed good psycho-
metric properties, including good item convergent and
discriminant validity and good internal consistency reli-
ability of the dimensions as well as sub-dimensions. The
FGVS was also able to discriminate between patients
according to the wearing of glasses after surgery and
according to the occurrence of another ocular disease
after surgery. Patients not wearing glasses after surgery
reported a more positive evaluation and greater advan-
tages of freedom from glasses than those who had to wear
glasses, and patients who had no other ocular disease
after surgery reported a more positive evaluation of sur-
gery than those who had ocular disease. Similar psycho-
metric results were observed for France and Spain. These
results demonstrate the validity of the final structure of
the FGVS.
Along with good psychometric results, a noteworthy
result of this study was the difference observed between
French and Spanish patients in their response patterns.
Spanish patients tended to answer more positively than
French patients to all FGVS items, and were more likely
to use the central answer choice than French patients.
French patients were more likely to use the intermediate
answer choices. Spanish patients tended to report a bet-
ter global evaluation of surgery and greater advantages of
freedom from glasses than French patients. This pro-
duced a statistically significant difference between coun-
tries in both scores. Three arguments could be put
forward to explain these differences: issues with cross-
cultural performances of the French and Spanish versions
of the FGVS, differences in the clinical status of French
and Spanish patients, or cultural and social differences
between France and Spain. First, one could argue that the
differences observed between French and Spanish
patients could be due to issues related to the cross-cul-
tural validity of the FGVS, such as construct or item bias.
However, the PCA found that the 2 versions had similar
Table 5: Psychometric validation of the final structure of the FGVS (N = 304).
Number of 
items
% at floor % at ceiling Range of 
Spearman 
item-scale 
correlations
% of items 
meeting the 
convergent 
validity 
criterion
% of items 
meeting the 
discriminant 
validity 
criterion*
Cronbach's 
alpha
Evaluation of 
the result
2 0.3 56.6 0.57 - 0.57 100% 50% 0.78
Feelings 4 2.0 47.7 0.66 - 0.77 100% 100% 0.91
Global 
judgment
3 2.0 55.3 0.54 - 0.60 100% 67% 0.84
Global 
evaluation
9 0.3 32.2 0.52 - 0.75 100% 100% 0.93
Practical 
advantages
5 1.0 20.1 0.55 - 0.65 100% 80% 0.82
Psychological 
advantages
3 3.3 40.8 0.79 - 0.85 100% 100% 0.89
Advantages 8 0.3 18.4 0.58 - 0.81 100% 100% 0.89
* For each item, the correlation coefficient with its own scale is compared to correlation coefficients with the other scales. The percentage of 
items for which the correlation with its own scale is greater than the correlation with all the other scales is reported.Berdeaux et al. BMC Ophthalmology 2010, 10:15
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structures, and a quasi-systematic difference in the item
responses was observed, indicating that issues with the
cross-cultural validity of the FGVS is unlikely to be the
major cause of these differences. Another explanation
could be the difference in patients' clinical status. How-
ever, except in the proportion of myopic, astigmatic and
hyperopic patients, French and Spanish patients were
comparable, especially regarding the use of glasses before
and after surgery. The most plausible explanation of the
difference in the response patterns between French and
Spanish patients in our study is the response style bias,
defined as "a systematic tendency to respond to a range of
questionnaire items on some other basis than the specific
item content" [35]. Two highly problematic issues in atti-
tude and survey research regarding response style bias
are acquiescence and extreme response style [36,37]. In
2004, van Herk et al [38] showed that Spanish respon-
dents tended to display higher acquiescence and to use
more extreme responses than did French respondents,
and our results are in line with those findings. The influ-
ence of some cultural characteristics of a society on the
way that questions are answered has been explored and is
well-known [39,40]. Thus the differences observed
between French and Spanish patients in the present
study, reinforced by the complexity of the role played by
cultural features in the response style bias, suggest that
the country effect should be systematically tested when
using the FGVS.
A ceiling effect was observed for the 'global evaluation'
score, which could be considered a limitation of our
Table 6: Known-group validity: results for groups presenting a statistically significant difference in FGVS 'global 
evaluation' and/or 'advantages' score(s) (N = 304).
Global evaluation scores Advantages scores
Sub-dimension scores Sub-dimension scores
Dimension 
score
Evaluation 
of the 
result
Feelings Global 
judgment
Dimension 
score
Practical 
advantages
Psychological 
advantages
Wearing 
glasses 
after 
surgery
Yes, always Mean (STD) 3.6 (1.4) 3.9 (1.2) 3.5 (1.6) 3.6 (1.4) 3.5 (1.0) 3.6 (1.0) 3.3 (1.3)
(N = 15) Median 4.6 4.5 4.8 4.3 3.8 3.6 3.0
Yes, 
sometimes
Mean (STD) 4.0 (1.0) 4.2 (0.7) 3.9 (1.1) 3.9 (1.2) 3.3 (1.0) 3.3 (0.9) 3.3 (1.3)
(N = 24) Median 4.2 4.0 4.4 4.3 3.0 3.1 3.0
No/Never Mean (STD) 4.6 (0.7) 4.6 (0.7) 4.5 (0.8) 4.6 (0.8) 3.9 (1.0) 3.9 (1.0) 3.9 (1.2)
(N = 265) Median 4.8 5.0 5.0 5.0 4.0 4.0 4.0
p-value <0.001 <0.001 <0.001 <0.001 0.006 0.007 0.017
Other 
ocular 
disease 
since 
surgery*
Yes Mean (STD) 3.8 (1.6) 3.9 (1.3) 3.6 (1.7) 3.8 (1.7) 3.4 (1.1) 3.5 (1.1) 3.3 (1.4)
(N = 21) Median 4.7 4.5 4.8 4.7 3.3 3.6 3.0
No Mean (STD) 4.5 (0.7) 4.6 (0.7) 4.5 (0.8) 4.5 (0.8) 3.8 (1.0) 3.8 (1.0) 3.8 (1.2)
(N = 283) Median 4.8 5.0 4.8 5.0 4.0 4.0 4.0
p-value 0.044 0.023 NS NS NS NS NS
* All 21 patients reported a different ocular disease since surgery, including for example conjunctivitis, problems with tears, sty or retinal 
detachment
Presented p-values are p-values of the difference between groups (Mann-Whitney-Wilcoxon or Kruskal-Wallis test); NS, Not SignificantBerdeaux et al. BMC Ophthalmology 2010, 10:15
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study. However, our study involved only patients who had
no complications during surgery that required them to
wear glasses and no post-surgery infectious complica-
tions. Therefore, all patients included were likely to be
globally satisfied with surgery, and results may be differ-
ent in a study based on a prospective study design.
Another limitation of the present study is that some
important psychometric properties, including concurrent
validity, as well as reproducibility (test-retest reliability)
and responsiveness, could not be assessed because the
study design used only one PRO instrument and one
evaluation. The psychometric validation of the FGVS
should therefore be completed by using the questionnaire
in another study in conjunction with other PRO instru-
ments and with several different time point assessments.
In addition, the questionnaire was administered by phone
in our study; in future research the acceptability of the
FGVS should also be analyzed when administered using
another mode of administration. Lastly, additional work
should assess the usefulness of the 3 items that were kept
in the questionnaire but that did not load on either
domain.
One could argue that our patient cohort was a mixed
group of individuals suffering from different eye condi-
tions which could affect patients' outcomes. Although
patients with presbyopia might have different expecta-
tions than patients with cataract, the number of patients
with presbyopia included in our survey was not big
enough to allow any inferences. Moreover, the question
of the relation between factors such as the age, gender or
medical history, and expectations is still not resolved.
Additional research with specific experimental designs
should be conducted to confirm these findings.
In our study design, all FGVS items were completed
after surgery. However, the structure of the final version
of the FGVS, measuring on the one hand the advantages
of no longer wearing glasses and evaluating on the other
hand patients' satisfaction with the IOL surgery, suggests
another potential future use of the questionnaire. The
first part of the questionnaire on the advantages of free-
dom from glasses could be answered by patients before
surgery in order to assess their expectations, while the
second part on patients' satisfaction could be answered
by patients after surgery in order to assess patients' satis-
faction. Thus, the first part could be used for different
purposes: first to describe the baseline expectations of
patients, then as a covariate in the analysis of the benefit
of surgery as measured by the 'global evaluation' score,
and finally, alongside other clinical criteria, to document
the patient's eligibility for surgery.
The final structure of the FGVS provides an overall
view with its two 'global evaluation' and 'advantages'
dimensions, as well as a more subtle view and particular
perspective with its five sub-dimensions. Therefore, we
recommend using a hierarchical process when analyzing
FGVS data, by first evaluating the two dimension scores,
and then, depending on the results obtained for dimen-
sion scores, evaluating the five sub-dimension scores.
Conclusions
Even though further validation analyses would be useful
to complete the present study, the final version of the
FGVS proved to be a reliable and valid PRO instrument
that enables the practical and psychological advantages of
freedom from glasses and patient satisfaction after multi-
focal IOL surgery to be assessed.
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